190 related articles for article (PubMed ID: 36568260)
1. Structural analysis of cannabinoids against EGFR-TK leads a novel target against EGFR-driven cell lines.
Lamtha T; Tabtimmai L; Songtawee N; Tansakul N; Choowongkomon K
Curr Res Pharmacol Drug Discov; 2022; 3():100132. PubMed ID: 36568260
[TBL] [Abstract][Full Text] [Related]
2. Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes.
De Petrocellis L; Ligresti A; Moriello AS; Allarà M; Bisogno T; Petrosino S; Stott CG; Di Marzo V
Br J Pharmacol; 2011 Aug; 163(7):1479-94. PubMed ID: 21175579
[TBL] [Abstract][Full Text] [Related]
3. Cannabidiol and Cannabigerol Inhibit Cholangiocarcinoma Growth In Vitro via Divergent Cell Death Pathways.
Viereckl MJ; Krutsinger K; Apawu A; Gu J; Cardona B; Barratt D; Han Y
Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740979
[TBL] [Abstract][Full Text] [Related]
4. Non-psychotropic cannabinoids as inhibitors of TET1 protein.
Antonyová V; Kejík Z; Brogyanyi T; Kaplánek R; Veselá K; Abramenko N; Ocelka T; Masařík M; Matkowski A; Gburek J; Abel R; Goede A; Preissner R; Novotný P; Jakubek M
Bioorg Chem; 2022 Jul; 124():105793. PubMed ID: 35462234
[TBL] [Abstract][Full Text] [Related]
5. CBG, CBD, Δ9-THC, CBN, CBGA, CBDA and Δ9-THCA as antioxidant agents and their intervention abilities in antioxidant action.
Dawidowicz AL; Olszowy-Tomczyk M; Typek R
Fitoterapia; 2021 Jul; 152():104915. PubMed ID: 33964342
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid receptor 1 binding activity and quantitative analysis of Cannabis sativa L. smoke and vapor.
Fischedick J; Van Der Kooy F; Verpoorte R
Chem Pharm Bull (Tokyo); 2010 Feb; 58(2):201-7. PubMed ID: 20118579
[TBL] [Abstract][Full Text] [Related]
7. Direct Quantitation of Phytocannabinoids by One-Dimensional
Dadiotis E; Mitsis V; Melliou E; Magiatis P
Molecules; 2022 May; 27(9):. PubMed ID: 35566314
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of UDP-Glucuronosyltransferase Enzymes by Major Cannabinoids and Their Metabolites.
Nasrin S; Watson CJW; Bardhi K; Fort G; Chen G; Lazarus P
Drug Metab Dispos; 2021 Dec; 49(12):1081-1089. PubMed ID: 34493601
[TBL] [Abstract][Full Text] [Related]
9. A novel cyclic NP1 reveals obstruction of EGFR kinase activity and attenuation of EGFR-driven cell lines.
Jiwacharoenchai N; Tabtimmai L; Kiriwan D; Suwattanasophon C; Seetaha S; Sinthuvanich C; Choowongkomon K
J Cell Biochem; 2022 Feb; 123(2):248-258. PubMed ID: 34633106
[TBL] [Abstract][Full Text] [Related]
10. Identification of tripeptides against tyrosine kinase domain of EGFR for lung cancer cell inhibition by in silico and in vitro studies.
Kiriwan D; Seetaha S; Jiwacharoenchai N; Tabtimmai L; Sousa SF; Songtawee N; Choowongkomon K
Chem Biol Drug Des; 2022 Mar; 99(3):456-469. PubMed ID: 34923743
[TBL] [Abstract][Full Text] [Related]
11. In Vitro and Clinical Evaluation of Cannabigerol (CBG) Produced via Yeast Biosynthesis: A Cannabinoid with a Broad Range of Anti-Inflammatory and Skin Health-Boosting Properties.
Perez E; Fernandez JR; Fitzgerald C; Rouzard K; Tamura M; Savile C
Molecules; 2022 Jan; 27(2):. PubMed ID: 35056807
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB
Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R
Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563
[TBL] [Abstract][Full Text] [Related]
13. Computational Investigation of 1, 3, 4 Oxadiazole Derivatives as Lead Inhibitors of VEGFR 2 in Comparison with EGFR: Density Functional Theory, Molecular Docking and Molecular Dynamics Simulation Studies.
Bilal MS; Ejaz SA; Zargar S; Akhtar N; Wani TA; Riaz N; Aborode AT; Siddique F; Altwaijry N; Alkahtani HM; Umar HI
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36358960
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of aldose reductase activity by Cannabis sativa chemotypes extracts with high content of cannabidiol or cannabigerol.
Smeriglio A; Giofrè SV; Galati EM; Monforte MT; Cicero N; D'Angelo V; Grassi G; Circosta C
Fitoterapia; 2018 Jun; 127():101-108. PubMed ID: 29427593
[TBL] [Abstract][Full Text] [Related]
15. Synthetic Strategies for Rare Cannabinoids Derived from
Nguyen GN; Jordan EN; Kayser O
J Nat Prod; 2022 Jun; 85(6):1555-1568. PubMed ID: 35648593
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
